Home > Insider Trading > Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc. (PHAT)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Do You Believe in the Growth Potential of Phathom Pharmaceuticals (PHAT)?

PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A copy of the letter can be downloaded here. Given concerns regarding the decreasing pace of U.S.

Keep Reading →

December 12th, 2024 - Hedge Fund Investor Letters News

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q3 2024 Earnings Call Transcript

Operator: Hello, and welcome to the Phathom Pharmaceuticals Third Quarter 2024 Earnings Results Call. At this time, all participants are in a listen-only mode.

Keep Reading →

November 11th, 2024 - News Transcripts

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q2 2024 Earnings Call Transcript

Operator: Hello, and welcome to Phathom Pharmaceuticals Second Quarter 2024 Earnings Results Call. [Operator Instructions] Please be advised that today's conference is being recorded.

Keep Reading →

August 12th, 2024 - News Transcripts

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript

Operator: Hello, and welcome to Phathom Pharmaceuticals First Quarter 2024 Earnings Results Call. [Operator Instructions] Please be advised that today's conference is being recorded.

Keep Reading →

May 13th, 2024 - News Transcripts

12 Most Shorted Stocks in 2024

Short-sellers may be annoying for corporations (and Redditors?), but investors usually find themselves thanking these companies for doing the often back-breaking and excruciating research that is required...

Keep Reading →

April 19th, 2024 - Hedge Funds News

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2023 Earnings Call Transcript

Phathom Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.8, expectations were $-0.92.

Keep Reading →

March 8th, 2024 - News Transcripts

Hedge Fund and Insider Trading News: Amber Capital UK LLP, Third Point LLC, D.E. Shaw, Odey Asset Management, Alameda Research, North Rock Digital, FedEx Corp (FDX), Domo, Inc. (DOMO), and More

Amber Capital UK LLP founder Joseph Oughourlian denied a news report that claimed he was in talks with several private equity funds to take control of Spanish defense group Indra Sistemas SA.

Keep Reading →

April 10th, 2023 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Anthony Scaramucci, Nelson Peltz, Bill Ackman, Leon Cooperman, Standard General LP, Comtech Telecomm. Corp. (CMTL), Tilly's, Inc. (TLYS), and More

SkyBridge Capital can buy back the stake it sold to collapsed cryptocurrency exchange FTX but the issue will likely take months to resolve, the investment firm’s founder Anthony Scaramucci told CNBC...

Keep Reading →

January 13th, 2023 - Hedge Funds Insider Trading

Were Hedge Funds Right About Phathom Pharmaceuticals, Inc. (PHAT)?

Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...

Keep Reading →

July 26th, 2021 - Hedge Funds News

Here is What Hedge Funds Think About Phathom Pharmaceuticals, Inc. (PHAT)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Keep Reading →

December 2nd, 2020 - Hedge Funds News